Cargando…

Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future

Since antiquity Man has been fascinated by the variations in human (and animal) growth. Stories and art abound about giants and little people. Modern genetics have solved some of etiologies at both extremes of growth. Serious study began with the pathophysiology of acromegaly followed by early attem...

Descripción completa

Detalles Bibliográficos
Autores principales: Graber, Evan, Reiter, Edward O., Rogol, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287422/
https://www.ncbi.nlm.nih.gov/pubmed/34290673
http://dx.doi.org/10.3389/fendo.2021.709936
_version_ 1783723915212750848
author Graber, Evan
Reiter, Edward O.
Rogol, Alan D.
author_facet Graber, Evan
Reiter, Edward O.
Rogol, Alan D.
author_sort Graber, Evan
collection PubMed
description Since antiquity Man has been fascinated by the variations in human (and animal) growth. Stories and art abound about giants and little people. Modern genetics have solved some of etiologies at both extremes of growth. Serious study began with the pathophysiology of acromegaly followed by early attempts at treatment culminating in modern endoscopic surgery and multiple pharmacologic agents. Virtually at the same time experiments with the removal of the pituitary from laboratory animals noted the slowing or stopping of linear growth and then over a few decades the extraction and purification of a protein within the anterior pituitary that restored, partially or in full, the animal’s growth. Human growth hormone was purified decades after those from large animals and it was noted that it was species specific, that is, only primate growth hormone was metabolically active in primates. That was quite unlike the beef and pork insulins which revolutionized the care of children with diabetes mellitus. A number of studies included mild enzymatic digestion of beef growth hormone to determine if those “cores” had biologic activity in primates and man. Tantalizing data showed minimal but variable metabolic efficacy leading to the “active core” hypothesis, for these smaller peptides would be amenable to peptide synthesis in the time before recombinant DNA. Recombinant DNA changed the landscape remarkably promising nearly unlimited quantities of metabolically active hormone. Eight indications for therapeutic use have been approved by the Food and Drug Administration and a large number of clinical trials have been undertaken in multiple other conditions for which short stature in childhood is a sign. The future predicts other clinical indications for growth hormone therapy (and perhaps other components of the GH?IGF-1 axis), longer-acting analogues and perhaps a more physiologic method of administration as virtually all methods at present are far from physiologic.
format Online
Article
Text
id pubmed-8287422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82874222021-07-20 Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future Graber, Evan Reiter, Edward O. Rogol, Alan D. Front Endocrinol (Lausanne) Endocrinology Since antiquity Man has been fascinated by the variations in human (and animal) growth. Stories and art abound about giants and little people. Modern genetics have solved some of etiologies at both extremes of growth. Serious study began with the pathophysiology of acromegaly followed by early attempts at treatment culminating in modern endoscopic surgery and multiple pharmacologic agents. Virtually at the same time experiments with the removal of the pituitary from laboratory animals noted the slowing or stopping of linear growth and then over a few decades the extraction and purification of a protein within the anterior pituitary that restored, partially or in full, the animal’s growth. Human growth hormone was purified decades after those from large animals and it was noted that it was species specific, that is, only primate growth hormone was metabolically active in primates. That was quite unlike the beef and pork insulins which revolutionized the care of children with diabetes mellitus. A number of studies included mild enzymatic digestion of beef growth hormone to determine if those “cores” had biologic activity in primates and man. Tantalizing data showed minimal but variable metabolic efficacy leading to the “active core” hypothesis, for these smaller peptides would be amenable to peptide synthesis in the time before recombinant DNA. Recombinant DNA changed the landscape remarkably promising nearly unlimited quantities of metabolically active hormone. Eight indications for therapeutic use have been approved by the Food and Drug Administration and a large number of clinical trials have been undertaken in multiple other conditions for which short stature in childhood is a sign. The future predicts other clinical indications for growth hormone therapy (and perhaps other components of the GH?IGF-1 axis), longer-acting analogues and perhaps a more physiologic method of administration as virtually all methods at present are far from physiologic. Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8287422/ /pubmed/34290673 http://dx.doi.org/10.3389/fendo.2021.709936 Text en Copyright © 2021 Graber, Reiter and Rogol https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Graber, Evan
Reiter, Edward O.
Rogol, Alan D.
Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title_full Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title_fullStr Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title_full_unstemmed Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title_short Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future
title_sort human growth and growth hormone: from antiquity to the recominant age to the future
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287422/
https://www.ncbi.nlm.nih.gov/pubmed/34290673
http://dx.doi.org/10.3389/fendo.2021.709936
work_keys_str_mv AT graberevan humangrowthandgrowthhormonefromantiquitytotherecominantagetothefuture
AT reiteredwardo humangrowthandgrowthhormonefromantiquitytotherecominantagetothefuture
AT rogolaland humangrowthandgrowthhormonefromantiquitytotherecominantagetothefuture